BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12237772)

  • 1. DNA topoisomerase I and II expression in drug resistant germ cell tumours.
    Berney DM; Shamash J; Gaffney J; Jordan S; Oliver RT
    Br J Cancer; 2002 Sep; 87(6):624-9. PubMed ID: 12237772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topoisomerase II alpha expression in testicular germ cell tumors.
    Dimov ND; Zynger DL; Luan C; Kozlowski JM; Yang XJ
    Urology; 2007 May; 69(5):955-61. PubMed ID: 17482942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary-tumour-transforming-gene 1 expression in testicular cancer.
    Pierconti F; Milardi D; Martini M; Grande G; Cenci T; Gulino G; Larocca LM; Rindi G; Pontecorvi A; De Marinis L
    Andrologia; 2015 May; 47(4):427-32. PubMed ID: 24754453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of CD30 expression in metastatic embryonal carcinoma: the effects of chemotherapy?
    Berney DM; Shamash J; Pieroni K; Oliver RT
    Histopathology; 2001 Oct; 39(4):382-5. PubMed ID: 11683938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and diagnostic significance of OCT4, CD117 and CD30 in germ cell tumors].
    Teng LH; Lu DH; Xu QZ; Fu YJ; Yang H; He ZL
    Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):711-5. PubMed ID: 16536313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPR30 is overexpressed in post-puberal testicular germ cell tumors.
    Franco R; Boscia F; Gigantino V; Marra L; Esposito F; Ferrara D; Pariante P; Botti G; Caraglia M; Minucci S; Chieffi P
    Cancer Biol Ther; 2011 Mar; 11(6):609-13. PubMed ID: 21278491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bilateral and synchronous testicular teratoma: a case report and literature review].
    Matabuena-Tamez P; Canepa-Fernández P; Valencia-García LC; Gutiérrez-Samperio C; Gallegos-Corona MA
    Cir Cir; 2015; 83(6):527-31. PubMed ID: 26164135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitfalls in the interpretation of specimens from patients with testicular tumours, with an emphasis on variant morphologies.
    Ulbright TM
    Pathology; 2018 Jan; 50(1):88-99. PubMed ID: 29129333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of primary standard cisplatin-based chemotherapy for clinical stage II non-seminomatous germ cell tumours of the testis.
    Culine S; Theodore C; Court BH; Perrin JL; Droz JP
    Br J Urol; 1997 Feb; 79(2):258-62. PubMed ID: 9052479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor-beta expression in human testicular germ cell tumors.
    Pais V; Leav I; Lau KM; Jiang Z; Ho SM
    Clin Cancer Res; 2003 Oct; 9(12):4475-82. PubMed ID: 14555521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of teratoma of the testis with retroperitoneal lymph nodes involved with malignant teratoma after chemotherapy].
    Muraki J; Nakazono M
    Nihon Hinyokika Gakkai Zasshi; 1993 Dec; 84(12):2162-5. PubMed ID: 7508531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
    Amato RJ; Ro JY; Ayala AG; Swanson DA
    Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of ERbeta1 and ERbeta2 in human seminoma, in embryonal carcinoma and in their adjacent intratubular germ cell neoplasia.
    Rago V; Romeo F; Giordano F; Ferraro A; Andò S; Carpino A
    Reprod Biol Endocrinol; 2009 Jun; 7():56. PubMed ID: 19493328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case of testicular cancer with malignant transformation in the residual retroperitoneal mature teratoma 8 years after the initial chemotherapy].
    Ito K; Iigaya T; Umezawa A
    Nihon Hinyokika Gakkai Zasshi; 1998 Jun; 89(6):622-6. PubMed ID: 9666691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors.
    Kundu SD; Feldman DR; Carver BS; Gupta A; Bosl GJ; Motzer RJ; Bajorin DF; Sheinfeld J
    J Urol; 2015 Feb; 193(2):513-8. PubMed ID: 25150639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroperitoneal teratoma with somatic malignant transformation: a papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy.
    Zeh N; Wild PJ; Bode PK; Kristiansen G; Moch H; Sulser T; Hermanns T
    BMC Urol; 2013 Feb; 13():9. PubMed ID: 23402579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial thrombosis after cisplatin-based chemotherapy for metastatic germ cell tumors.
    Cheng E; Berthold DR; Moore MJ; Duran I
    Acta Oncol; 2009; 48(3):475-7. PubMed ID: 18932096
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.
    Gerl A; Clemm C; Schmeller N; Dienemann H; Weiss M; Kriegmair M; Löhrs U; Wilmanns W
    Br J Cancer; 1994 Nov; 70(5):960-5. PubMed ID: 7524606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors of the testis.
    Jacqmin D
    Eur Urol; 2008 Feb; 53(2):272-3. PubMed ID: 18045771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.